News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Novartis Pharma Adds High-Dose Tablet To Its Antihypertensive Treatment Diovan
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Tokyo (JCNN) - Novartis Pharma has announced that it has launched Diovan Tablet 160mg, a high-dose preparation of its antihypertensive drug.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
MORE ON THIS TOPIC
Lymphoma
AbbVie, Genmab’s Bispecific Misses Key Overall Survival Endpoint in Phase III Lymphoma Study
January 19, 2026
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH LOTTE BIOLOGICS
LOTTE Biologics Tightens Global Quality as Syracuse ADC Hub Ramps for 2026
January 19, 2026
·
2 min read
·
Jennifer Smith-Parker
Sponsored
After the JPM Hype, a Reality Check: Why your 2026 Strategy Hinges on your Manufacturing Toolkit
January 19, 2026
·
3 min read
Business
JPM26: Protagonist Has a $400M Decision To Make. It’s a No-Brainer
January 16, 2026
·
2 min read
·
Annalee Armstrong
